Establishing a Board Evaluation Mechanism Post-Listing: Requirements and Disclosure

The Hong Kong Stock Exchange (HKEX) formally codified board evaluation requirements into the Listing Rules in January 2022, mandating that all listed issuers conduct a board performance review at least annually. Three years on, the 2025 enforcement cycle reveals a sharpening of scrutiny: in its 2024 review of issuer compliance, the HKEX identified board evaluation disclosures as a recurring area of deficiency, with 38% of sampled issuers failing to provide a meaningful description of the evaluation process or its outcomes. This is not a matter of ticking a box under Appendix 14 of the Main Board Listing Rules. The Corporate Governance Code (CGC), specifically Code Provisions C.2.7 and C.2.8, now requires issuers to explain how the board evaluates itself — not merely that it does so. For CFOs, company secretaries, and boards of newly-listed entities, the gap between a pro-forma questionnaire and a substantive evaluation mechanism carries direct implications for sponsor liability, investor confidence, and potential enforcement action. This article dissects the regulatory framework, the mechanics of a compliant evaluation, and the disclosure standards that the HKEX expects from Main Board and GEM issuers alike.

The Regulatory Architecture: From Code Provision to Enforceable Rule

The board evaluation requirement sits within the broader framework of the Corporate Governance Code, but its enforcement has shifted from a “comply or explain” soft standard to a de facto mandatory disclosure obligation. The HKEX’s 2024 Consultation Conclusions on Corporate Governance (published in December 2024) confirmed that the Exchange will now request a detailed breakdown of the evaluation methodology in annual reviews, and will publicly censure issuers whose disclosures are “boilerplate or generic.”

Code Provisions C.2.7 and C.2.8: The Core Obligations

Code Provision C.2.7 states that the board should conduct a formal evaluation of its own performance and that of its committees at least annually. Code Provision C.2.8 extends this to an evaluation of individual directors’ contributions. For issuers listed on the Main Board, these provisions are mandatory under the Listing Rules’ Appendix 14, which applies to all issuers with financial years commencing on or after 1 January 2022. GEM issuers are subject to equivalent provisions under GEM Listing Rules Chapter 17.

The critical distinction lies in the word “formal.” The HKEX’s 2023 “Guidance on Board Performance Evaluation” (GL-117-2023) defines “formal” as a structured process with documented criteria, a defined methodology (e.g., peer review, self-assessment, external facilitator), and a written report to the board. An informal discussion among directors, or a single-questionnaire circulated without follow-up, does not meet the standard.

The 2024-2025 Enforcement Shift

The HKEX’s 2024 Annual Corporate Governance Review, published in March 2025, flagged board evaluation as one of three “persistent areas of non-compliance.” The review examined 200 randomly selected annual reports for FY2023 and FY2024. Key findings:

• 62% of issuers disclosed that a board evaluation was conducted, but only 41% described the evaluation process in any detail.
• 19% of issuers used an external facilitator, down from 22% in the prior review period.
• 8% of issuers explicitly stated that no board evaluation was conducted, with 5% providing a comply-or-explain rationale that the HKEX deemed “inadequate.”

The HKEX’s Listing Division has since issued formal letters to 14 issuers, requesting further information on their evaluation mechanisms. Two issuers received public censures in Q1 2025 for “materially deficient” disclosures under Listing Rule 2.13(2), which requires that all information in a listing document or annual report be “accurate and complete in all material respects.”

Designing a Compliant Evaluation Mechanism: Structural Choices

The board evaluation mechanism is not a one-size-fits-all exercise. The structure must reflect the issuer’s size, industry, board composition, and the nature of its committees. For a newly-listed company, the first post-IPO board evaluation carries particular weight, as it sets the baseline against which future reviews will be measured.

Internal vs. External Facilitation: The Trade-Off

Code Provision C.2.7 does not mandate external facilitation, but the HKEX’s guidance strongly encourages it for issuers with a market capitalisation above HKD 10 billion or those with a complex governance structure (e.g., dual-class shares, VIE structures, or significant cross-border operations). The rationale is straightforward: an external facilitator provides objectivity and a benchmark against peer issuers.

For smaller issuers, an internal evaluation is permissible provided it meets the “formal” standard. The typical internal model involves:

• A self-assessment questionnaire distributed to all directors, covering board dynamics, meeting effectiveness, strategy oversight, and committee performance.
• A collation of responses by the company secretary or a designated governance officer.
• A board session to discuss the aggregated results, with minutes recorded.

The risk of the internal model is groupthink or a reluctance to criticise. The HKEX’s 2023 guidance explicitly warns that “an evaluation which does not generate any actionable recommendations may be viewed as insufficiently rigorous.”

The Role of the Nomination Committee

Under Code Provision B.3.1, the nomination committee is responsible for reviewing the board’s structure, size, and composition. The board evaluation feeds directly into this review. The nomination committee should receive the evaluation report and use it to recommend changes to board composition, director tenure, or committee membership.

A 2024 study by the Hong Kong Institute of Chartered Secretaries (HKICS) found that 73% of issuers whose nomination committee actively reviewed the evaluation results reported improved board effectiveness scores in the subsequent year. The study surveyed 150 Main Board issuers with financial years ending December 2023.

Individual Director Evaluation: The Sensitive Component

Code Provision C.2.8 requires evaluation of individual directors’ contributions. This is the most sensitive aspect of the process, particularly for founder-directors or long-tenured board members. The HKEX does not prescribe a specific methodology, but its guidance lists acceptable approaches:

• Peer review: each director evaluates every other director (including the chair) against pre-defined criteria.
• Self-assessment with chair interview: the director completes a self-assessment, followed by a one-on-one discussion with the board chair.
• 360-degree feedback: input from senior management, external advisors, and committee chairs.

The results of individual evaluations are not required to be disclosed in the annual report — only the fact that they were conducted and the methodology used. However, if the evaluation identifies a specific director’s performance as a material concern, the board must consider whether disclosure is necessary under Listing Rule 2.13(2) to avoid misleading shareholders.

Disclosure Standards: What the Annual Report Must Contain

The annual report is the primary vehicle for board evaluation disclosure. The HKEX’s 2024 review made clear that a single sentence — “The board conducted an evaluation of its performance during the year” — is no longer sufficient.

Mandatory Disclosure Elements

The HKEX’s “Guidance on Board Performance Evaluation” (GL-117-2023) lists the following as mandatory disclosure items in the Corporate Governance Report:

1. Whether the evaluation was conducted internally or with an external facilitator. If external, the name of the facilitator and a brief description of its qualifications.
2. The evaluation methodology, including the criteria used (e.g., board dynamics, strategic oversight, risk management, committee effectiveness).
3. A summary of the key findings and any actions taken or planned in response.
4. The frequency of evaluation (must be at least annual, but many issuers opt for a biennial external review with annual internal check-ins).
5. Whether individual director evaluations were conducted and, if so, the methodology used.

Common Disclosure Deficiencies

The 2024 review identified three recurring deficiencies:

• Vague methodology descriptions: Issuers stating “questionnaires were used” without specifying the number of questions, the response rate, or the criteria.
• Absence of findings: Issuers describing the process but not disclosing any results or actions. The HKEX considers this a red flag, as it suggests the evaluation generated no actionable insights.
• Inconsistent committee coverage: Issuers evaluating the full board but omitting one or more committees (e.g., the audit committee or remuneration committee). Code Provision C.2.7 explicitly covers all board committees.

The “Comply or Explain” Trap

Issuers that choose not to conduct a board evaluation must provide a “considered explanation” under the comply-or-explain framework. The HKEX’s 2024 review found that 8% of sampled issuers fell into this category, and 5% of explanations were deemed inadequate.

An inadequate explanation is one that states a generic reason — e.g., “the board considers the current structure sufficient” — without reference to the issuer’s specific circumstances. A compliant explanation might cite the issuer’s small board size (e.g., three directors), its recent listing (less than 12 months), or a planned external review in the coming year. The HKEX expects the explanation to be “specific, reasoned, and tailored to the issuer’s facts.”

Practical Implementation for Newly-Listed Issuers

For a company that has just completed its IPO, the first board evaluation is a critical governance milestone. The sponsor and legal counsel should address the evaluation mechanism in the pre-listing corporate governance framework, as the HKEX will review the first annual report’s governance disclosures as part of its post-listing compliance monitoring.

Timing and First-Year Considerations

The Listing Rules require the first board evaluation to be conducted within the issuer’s first full financial year after listing. For an issuer that lists in September 2025 with a December financial year-end, the evaluation must cover the period from listing date (September 2025) to December 2025, and the results must be disclosed in the 2025 annual report.

The HKEX’s 2023 guidance acknowledges that a first-year evaluation may be less comprehensive than subsequent reviews, given the board’s limited operating history. However, the issuer must still meet the “formal” standard. A practical approach is to engage an external facilitator for the first evaluation, establishing a baseline and demonstrating commitment to governance from the outset.

Interaction with Sponsor Obligations

Under the SFC’s Code of Conduct for Sponsors (paragraph 17.6), a sponsor must satisfy itself that the issuer has “adequate systems and controls” to comply with post-listing obligations, including corporate governance requirements. The board evaluation mechanism falls within this scope. Sponsors should document the issuer’s planned evaluation process in the due diligence file and confirm that the board has approved the mechanism before listing.

Failure to do so could expose the sponsor to liability if the issuer subsequently fails to comply. In 2024, the SFC reprimanded one sponsor for inadequate due diligence on an issuer’s governance framework, specifically citing the absence of a documented board evaluation policy.

Cross-Border Structures: Additional Considerations

For issuers with a PRC operating entity under a VIE structure, or a Cayman/Bermuda holding company with a Hong Kong listing, the board evaluation must cover the entire group governance structure. The evaluation should assess the effectiveness of the VIE agreements, the independence of the PRC nominee directors, and the flow of information between the Hong Kong board and the PRC operating board.

The HKEX’s 2024 “Guidance on VIE Structures” (GL-117-2024) reminds issuers that the board evaluation must include a review of the VIE contractual arrangements and the directors’ oversight of those arrangements. Issuers with VIE structures should engage legal counsel experienced in both Hong Kong and PRC corporate law to ensure the evaluation criteria address the unique risks of the VIE model.

Actionable Takeaways

1. The board evaluation mechanism must be documented in the corporate governance framework before listing, with the sponsor confirming its adequacy in the due diligence file.
2. The annual report must disclose the evaluation methodology, key findings, and any actions taken — a single sentence of compliance will trigger HKEX scrutiny.
3. External facilitation is strongly recommended for issuers above HKD 10 billion market cap or those with complex structures, as the HKEX views internal reviews as higher-risk for groupthink.
4. Individual director evaluations under Code Provision C.2.8 must be conducted, and the methodology disclosed, even if the results remain confidential.
5. For VIE-structure issuers, the board evaluation must explicitly cover the VIE contractual arrangements and the PRC operating board’s governance effectiveness.